Some of the definitions concerning polypharmacy that can be encountered in my readings can be more than one definition aspect. The first description of polypharmacy is the utilization of numerous pharmacies, which is a chief public health concern. This happens as the multiple prescribers in the industry, the ever readily available of supplements, and the use of OTC medications are some of the experienced challenges affecting the prescription for the aged population ( Chamberlain College of Nursing, 2018). Secondly, numerous prescribers, as well as care providers, the use of OTC drugs, the cost adherence, the availability of supplements as well as the herbals, are still problems affecting the prescriptions for the adults (Terrery & Nicoteri, 2016). Moreover, the use of several medicine drugs is what is referred to as polypharmacy, which usually affects the older population experiencing multi-morbidity, results as one or more medicine drugs can be employed as a therapeutic modality to treat each condition experienced (Masnoon, Skakib, & Caughey, 2017).
The self-medication is a risk factor which contributes to the polypharmacy in most of the cases. The primary rationale here is evidenced based on that most of the patients usually buy medicine from the nearest local places as they do self-prescriptions and purchase, and this increases the risk factors of polypharmacy. Moreover, due to the rising status of the economy and the escalation of the cost of medicinal drugs the patients are often like to use the medicines that had been prescribed for them in the past and this enhances the risks of polypharmacy as a result of the self-medications (Maher, Hanlon, & Hajjar, 2014),
The aspect of chronic comorbidities is a risk factor that results in the use of polypharmacy. For example, if the patient has been diagnosed with conditions such as diabetes, cancer, dementia, cardiorespiratory illness, infectious diseases, these patients are likely to be subjected to polypharmacy. Sometimes, when patients have different care providers with separate chart sheets, they are likely to subject the patient to polypharmacy (Maher, Hanlon, & Hajjar, 2014).
Some of the interventions that I can take as nursing practitioner is enhance a comprehensive review of the patient treatment sheet to avoid an element of medication duplicate which might occur during the transmission of the patient from one facility to another one or even correctly check the information given to the patient by the chemist to avoid polypharmacy issues. The brown bag review technique is the strategy where the patient is encouraged, carrying all medical history to allow the comprehensive review to prevent the element of subjecting the patient into polypharmacy (McGrath et al., 2017). Another intervention strategy is to create a thorough follow up with the patients. The planning aid at the time of doing a prescription of medication as it provides a complete developed plan to monitor and assess the patient regularly. The comprehensive follow up method enables the patient to understand the effects and symptoms that may results due to medication withdrawal as it provides the necessary, which can cause the return of the condition if the medication is not taken as per the prescription.